Equitable Trust Co. lowered its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 1.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 24,705 shares of the company’s stock after selling 488 shares during the quarter. Equitable Trust Co.’s holdings in Zoetis were worth $4,025,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of ZTS. AMF Tjanstepension AB boosted its stake in Zoetis by 23.4% in the third quarter. AMF Tjanstepension AB now owns 105,376 shares of the company’s stock valued at $20,594,000 after acquiring an additional 20,001 shares in the last quarter. CWM LLC boosted its stake in Zoetis by 1.8% in the third quarter. CWM LLC now owns 19,330 shares of the company’s stock valued at $3,777,000 after acquiring an additional 339 shares in the last quarter. LVW Advisors LLC boosted its stake in Zoetis by 11.8% in the third quarter. LVW Advisors LLC now owns 1,470 shares of the company’s stock valued at $287,000 after acquiring an additional 155 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Zoetis by 307.5% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,930 shares of the company’s stock valued at $572,000 after acquiring an additional 2,211 shares in the last quarter. Finally, Valeo Financial Advisors LLC boosted its stake in Zoetis by 1.1% in the third quarter. Valeo Financial Advisors LLC now owns 8,028 shares of the company’s stock valued at $1,568,000 after acquiring an additional 91 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.
Zoetis Trading Down 1.6 %
NYSE ZTS opened at $171.37 on Monday. The stock has a market capitalization of $77.32 billion, a P/E ratio of 32.21, a P/E/G ratio of 2.77 and a beta of 0.90. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The firm has a 50-day moving average price of $169.26 and a 200 day moving average price of $179.22. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.
Zoetis Announces Dividend
Wall Street Analyst Weigh In
Several equities analysts have issued reports on ZTS shares. Stifel Nicolaus decreased their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Morgan Stanley reduced their target price on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a report on Wednesday, January 29th. Leerink Partners initiated coverage on shares of Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price for the company. Finally, UBS Group initiated coverage on shares of Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price for the company. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $215.00.
Get Our Latest Analysis on Zoetis
About Zoetis
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Featured Stories
- Five stocks we like better than Zoetis
- Insider Trades May Not Tell You What You Think
- Why Waste Management Stock Is a Top Defensive Play Now
- Best Aerospace Stocks Investing
- 2 Defensive Energy Stocks to Hedge Against Trade Turmoil
- What is a Dividend King?
- 3 Mining Stocks Poised to Ride the Precious Metals Boom
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.